Evidence map›Paper›PMID 34113822›Full record

ArticleiScience2021

Identification and characterization of andalusicin: N-terminally dimethylated class III lantibiotic from

Anastasiia Grigoreva, Julia Andreeva, Dmitry Bikmetov, Anastasiia Rusanova, Marina Serebryakova, Andrea Hernandez Garcia, Darya Slonova, Satish K Nair, Guy Lippens, Konstantin Severinov and 1 more

Abstract read
In one paragraph

Article in iScience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Whole Genome Sequencing ofMicroorganisms · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Anastasiia GrigorevaCenter of Life Sciences, Skolkovo Institute of Science and Technology, 121205 Moscow, Russia.
Julia AndreevaCenter of Life Sciences, Skolkovo Institute of Science and Technology, 121205 Moscow, Russia.
Dmitry BikmetovCenter for Precision Genome Editing and Genetic Technologies for Biomedicine, Institute of Gene Biology, Russian Academy of Sciences, Moscow 119334, Russia.
Anastasiia RusanovaInstitute of Gene Biology, Russian Academy of Sciences, Moscow 119334, Russia.
Marina SerebryakovaInstitute of Gene Biology, Russian Academy of Sciences, Moscow 119334, Russia.
Andrea Hernandez GarciaDepartment of Biochemistry, University of Illinois at Urbana-Champaign, Champaign, IL 61801 USA.
Darya SlonovaCenter of Life Sciences, Skolkovo Institute of Science and Technology, 121205 Moscow, Russia.
Satish K NairDepartment of Biochemistry, University of Illinois at Urbana-Champaign, Champaign, IL 61801 USA.
Guy LippensToulouse Biotechnology Institute (TBI), Université de Toulouse, CNRS, INRA, INSA, Toulouse 31077, France.
Konstantin SeverinovCenter of Life Sciences, Skolkovo Institute of Science and Technology, 121205 Moscow, Russia.
Svetlana DubileyCenter of Life Sciences, Skolkovo Institute of Science and Technology, 121205 Moscow, Russia.

Funding

Structural /Mechanistic Study of Lantibiotic Biosynthetic Enzymes & AutoimmunityR01GM079038 · NIGMS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI NAIR, SATISH K · 2006 to 2023
$3.7M
NIGMS NIH HHS R01 GM079038
6 · The paper itself

Abstract

Lanthipeptides, ribosomally synthesized and post-translationally modified peptides (RiPPs), can be divided into five classes based on their structures and biosynthetic pathways. Class I and II lanthipeptides have been well characterized, whereas less is known about members of the other three classes. Here, we describe a new family of class III lanthipeptides from

Indexed as

BiochemistryBiosynthesisChemistryMedical biochemistry

Identifiers

PMID34113822
PMCPMC8169954

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.